GSRX Industries Inc.
GSRX Industries Inc. (GSRX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
gsrx · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
GSRX Industries Inc.You GSRX | $0M | N/A | — | -$0.56 |
 Bloomios, Inc. BLMS | $0M | N/A | — | -$1.04 |
 Biostax Corp. BTAX | $0M | N/A | — | -$0.03 |
 CEN Biotech, Inc. CENBF | $0M | N/A | — | -$0.02 |
 HST Global, Inc. HSTC | $30M | N/A | — | -$0.01 |
 MJ Holdings, Inc. MJNE | $0M | N/A | — | -$0.07 |
 Neurogenesis, Inc. NEUN | $0M | 17.92x | — | $0.00 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for GSRX Industries Inc. (GSRX) measures how much investors pay for each dollar of the company's trailing earnings. GSRX's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.56.
Frequently asked questions
GSRX pe ratio · 6 questionsGSRX's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.56. Data sourced from Financial Modeling Prep via GSRX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · GSRX Industries Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09